Literature DB >> 20887783

Endogenous enzymes (NOX and ECSOD) regulate smoke-induced oxidative stress.

Angela K Tollefson1, Rebecca E Oberley-Deegan, Kiel T Butterfield, Michael E Nicks, Michael R Weaver, Linda K Remigio, Jessica Decsesznak, H W Chu, Donna L Bratton, David W Riches, Russell P Bowler.   

Abstract

Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the United States and the incidence is increasing as the population ages. Cigarette smoking is the primary risk factor; however, only a minority of smokers develop the disease. Inhalation of cigarette smoke introduces an abundance of free radicals into the lungs, causing oxidative stress and inflammation. We hypothesized that after the initial burst of oxidative stress associated with cigarette smoke exposure, a sustained source of endogenous free radical production is modulated by the antioxidant enzyme extracellular superoxide dismutase (ECSOD) and the superoxide-generating complex NADPH oxidase (NOX). Primary mouse macrophages exposed to cigarette smoke extract exhibited increased oxidative stress as indicated by fluorogenic dyes and isoprostane concentration, which was suppressed in the presence of both a superoxide dismutase mimetic and a NOX inhibitor. Similarly, primary macrophages isolated from ECSOD-overexpressing mice or NOX-deficient mice showed reduced oxidative stress in response to cigarette smoke treatment. In addition, both reduced glutathione and cytokines (MIP2 and IFNγ) were increased in bronchoalveolar lavage fluid of wild-type mice exposed to cigarette smoke but not in ECSOD-overexpressing or NOX-deficient mice. These data suggest that the mechanisms underlying the host defense against cigarette smoke-induced oxidative damage and subsequent development of COPD may include endogenous oxidases and antioxidant enzymes.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20887783      PMCID: PMC3780970          DOI: 10.1016/j.freeradbiomed.2010.09.022

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  48 in total

Review 1.  Oxidative stress in airways: is there a role for extracellular superoxide dismutase?

Authors:  Russell P Bowler; James D Crapo
Journal:  Am J Respir Crit Care Med       Date:  2002-12-15       Impact factor: 21.405

2.  The effect of arsenic in tobacco on primary neoplasms of the lungs of albino mice.

Authors:  J M ESSENBERG; A M LEAVITT; E GAFFNEY
Journal:  West J Surg Obstet Gynecol       Date:  1956-01

Review 3.  The macrophage in chronic obstructive pulmonary disease.

Authors:  S D Shapiro
Journal:  Am J Respir Crit Care Med       Date:  1999-11       Impact factor: 21.405

4.  Genetically increased antioxidative protection and decreased chronic obstructive pulmonary disease.

Authors:  Klaus Juul; Anne Tybjaerg-Hansen; Stefan Marklund; Peter Lange; Børge G Nordestgaard
Journal:  Am J Respir Crit Care Med       Date:  2006-01-06       Impact factor: 21.405

5.  The utility of superoxide dismutase in studying free radical reactions. I. Radicals generated by the interaction of sulfite, dimethyl sulfoxide, and oxygen.

Authors:  J M McCord; I Fridovich
Journal:  J Biol Chem       Date:  1969-11-25       Impact factor: 5.157

6.  Inflammatory cells as a source of airspace extracellular superoxide dismutase after pulmonary injury.

Authors:  Roderick J Tan; Janet S Lee; Michelle L Manni; Cheryl L Fattman; Jacob M Tobolewski; Mingquan Zheng; Jay K Kolls; Thomas R Martin; Tim D Oury
Journal:  Am J Respir Cell Mol Biol       Date:  2005-10-13       Impact factor: 6.914

Review 7.  Immunology of asthma and chronic obstructive pulmonary disease.

Authors:  Peter J Barnes
Journal:  Nat Rev Immunol       Date:  2008-02-15       Impact factor: 53.106

8.  Superoxide dismutase 3, extracellular (SOD3) variants and lung function.

Authors:  Koustav Ganguly; Martin Depner; Cheryl Fattman; Kiflai Bein; Tim D Oury; Scott C Wesselkamper; Michael T Borchers; Martina Schreiber; Fei Gao; Erika von Mutius; Michael Kabesch; George D Leikauf; Holger Schulz
Journal:  Physiol Genomics       Date:  2009-03-24       Impact factor: 3.107

9.  Tobacco smoke as a mouse lung carcinogen.

Authors:  H Witschi
Journal:  Exp Lung Res       Date:  1998 Jul-Aug       Impact factor: 2.459

10.  Extracellular superoxide dismutase haplotypes are associated with acute lung injury and mortality.

Authors:  John J Arcaroli; John E Hokanson; Edward Abraham; Mark Geraci; James R Murphy; Russell P Bowler; Charles A Dinarello; Lori Silveira; Jeff Sankoff; Daren Heyland; Paul Wischmeyer; James D Crapo
Journal:  Am J Respir Crit Care Med       Date:  2008-10-23       Impact factor: 21.405

View more
  24 in total

Review 1.  NOX Modifiers-Just a Step Away from Application in the Therapy of Airway Inflammation?

Authors:  Joanna Wieczfinska; Milena Sokolowska; Rafal Pawliczak
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

2.  HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress.

Authors:  Vonetta M Williams; Maria Filippova; Ubaldo Soto; Penelope J Duerksen-Hughes
Journal:  Future Virol       Date:  2011-01-01       Impact factor: 1.831

3.  C-rac-king the Code of Smoke-induced Pneumonia Susceptibility.

Authors:  Lee J Quinton
Journal:  Am J Respir Crit Care Med       Date:  2018-11-15       Impact factor: 21.405

Review 4.  Antioxidant pharmacological therapies for COPD.

Authors:  Irfan Rahman; William MacNee
Journal:  Curr Opin Pharmacol       Date:  2012-02-18       Impact factor: 5.547

5.  Cigarette smoke extract stimulates epithelial-mesenchymal transition through Src activation.

Authors:  Hongqiao Zhang; Honglei Liu; Zea Borok; Kelvin J A Davies; Fulvio Ursini; Henry Jay Forman
Journal:  Free Radic Biol Med       Date:  2012-02-04       Impact factor: 7.376

Review 6.  Pharmacological antioxidant strategies as therapeutic interventions for COPD.

Authors:  Irfan Rahman
Journal:  Biochim Biophys Acta       Date:  2011-11-09

7.  The R213G polymorphism in SOD3 protects against allergic airway inflammation.

Authors:  Rohit Gaurav; Jason T Varasteh; Michael R Weaver; Sean R Jacobson; Laura Hernandez-Lagunas; Qing Liu; Eva Nozik-Grayck; Hong Wei Chu; Rafeul Alam; Børge G Nordestgaard; Camilla J Kobylecki; Shoaib Afzal; Geoffrey L Chupp; Russell P Bowler
Journal:  JCI Insight       Date:  2017-09-07

8.  Quit smoking to outsmart atherogenesis: Molecular mechanisms underlying clinical evidence.

Authors:  Jessica Gambardella; Celestino Sardu; Cosimo Sacra; Carmine Del Giudice; Gaetano Santulli
Journal:  Atherosclerosis       Date:  2016-12-16       Impact factor: 5.162

9.  A common polymorphism in extracellular superoxide dismutase affects cardiopulmonary disease risk by altering protein distribution.

Authors:  John M Hartney; Timothy Stidham; David A Goldstrohm; Rebecca E Oberley-Deegan; Michael R Weaver; Zuzana Valnickova-Hansen; Carsten Scavenius; Richard K P Benninger; Katelyn F Leahy; Richard Johnson; Fabienne Gally; Beata Kosmider; Angela K Zimmermann; Jan J Enghild; Eva Nozik-Grayck; Russell P Bowler
Journal:  Circ Cardiovasc Genet       Date:  2014-08-01

10.  Cigarette Smoke Induces Human Epidermal Receptor 2-Dependent Changes in Epithelial Permeability.

Authors:  Rangnath Mishra; Daniel Foster; Vihas T Vasu; Jyoti V Thaikoottathil; Beata Kosmider; Hong Wei Chu; Russell P Bowler; James H Finigan
Journal:  Am J Respir Cell Mol Biol       Date:  2016-06       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.